Obesity may change how immune drug works – study seeks safer dosing
NCT ID NCT04818177
First seen Mar 01, 2026 · Last updated May 15, 2026 · Updated 13 times
Summary
This study looked at how obesity affects the way the body processes immunoglobulin G (IgG), a drug used to treat immune deficiency. Researchers wanted to find the best dose for obese patients to avoid side effects from too much medication. The study included 40 adults aged 18 to 75 who were already taking IgG. By measuring drug levels in the blood, the team aimed to create safer dosing guidelines.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Robert Wood Johnson University Hospital Somerset
Somerville, New Jersey, 08876, United States
Conditions
Explore the condition pages connected to this study.